Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Clinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled trial.
Neurodegenerative Diseases: Might Citrus Flavonoids Play a Protective Role?
Olfactory dysfunction in Multiple Sclerosis: A scoping review of the literature.
Intertwining extracellular nucleotides and their receptors with Ca2+ in determining adult neural stem cell survival, proliferation and final fate.
Increased expression of Tbet in CD4(+) T cells from clinically isolated syndrome patients at high risk of conversion to clinically definite MS.
Paraparetic Guillain-Barré syndrome: Non-demyelinating reversible conduction failure restricted to the lower limbs.
Epstein-Barr virus and multiple sclerosis. From evidence to therapeutic strategies.
Altering the course of disease in multiple sclerosis: many large steps forward.
Interleukin-1β impedes oligodendrocyte progenitor cell recruitment and white matter repair following chronic cerebral hypoperfusion.
Importance of early treatment initiation in the clinical course of multiple sclerosis.
Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis.
Considerations in the development of generic disease therapies for multiple sclerosis.
Engineering three dimensional micro nerve tissue using postnatal stem cells from human dental apical papilla.
Mitochondrial STAT3 is negatively regulated by SOCS3 and upregulated after spinal cord injury.
How human IgGs against DNA recognize oligonucleotides and DNA.
Spinal Cord in Multiple Sclerosis: Magnetic Resonance Imaging Features and Differential Diagnosis.
Features of idebenone and related short-chain quinones that rescue ATP levels under conditions of impaired mitochondrial complex I.
Tead1 regulates the expression of Peripheral Myelin Protein 22 during Schwann cell development.
PRDX6 controls multiple sclerosis by suppressing inflammation and blood brain barrier disruption.
Medical marijuana patient counseling points for health care professionals based on trends in the medical uses, efficacy, and adverse effects of cannabis-based pharmaceutical drugs.
"Immunometabolism and autoimmunity".
Telmisartan-mediated metabolic profile conferred brain protection in diabetic hypertensive rats as evidenced by magnetic resonance imaging, behavioral studies and histology.
The role of AQP4 in neuromyelitis optica: More answers, more questions.
Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis.
Pathoetiology of multiple sclerosis: are we barking up the wrong tree?
Pages
« first
‹ previous
…
733
734
735
736
737
738
739
740
741
…
next ›
last »